Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
16 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250516024813/en/Coya-Therapeutics-to-Participate-at-the-H.C.-Wainwright-3rd-Annual-BioConnect-Investor-Conference
13 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250513705163/en/Coya-Therapeutics-Reports-First-Quarter-Financial-Results-and-Provides-a-Corporate-Update
08 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250508864726/en/Coya-Therapeutics-to-Participate-in-Two-Upcoming-Conferences-in-May-2025
24 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250424949204/en/Coya-Therapeutics-Announces-Positive-Interim-Results-of-an-Investigator-Initiated-Open-Label-Study-with-Low-Dose-IL-2-and-CTLA4-Ig-Combination-Treatment-in-Five-Patients-with-Mild-to-Moderate-Frontotemporal-Dementia
24 Apr 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/coya-therapeutics-announces-positive-interim-results-of-an-investigator-initiated-ope-1019113
21 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250421341942/en/Coya-Therapeutics-Announces-Publication-of-GLP-1LD-IL-2-Combination-Biologic-COYA-303-Demonstrating-Synergistic-Enhancement-of-Regulatory-T-Cell-Function-and-Protection-Against-Treg-Apoptosis-Cell-Death
ABOUT THIS PAGE